Monte Rosa Therapeutics, Inc.

Q2 2026 13F Holders

Symbol
GLUE
CUSIP
61225M102
Type
Equity
Class
COM
Num filings
203
Total reported value, excl. options
$2.31 B
Manager Report Date Value ($000) Shares Option Type